Peptide Atlas · Peptide

Ipamorelin

Ipamorelin is the pentapeptide Aib-His-D-2-Nal-D-Phe-Lys-NH2, described as the first selective growth hormone secretagogue; it releases growth hormone through a GHRP-like receptor with potency and efficacy similar to GHRP-6.

emerging

provisional
PubChem 9831659
2 citations
0 discussions
0 followers

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

emerging — human data exists, and it is thin or contested

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

created page created as 'Ipamorelin' · 2026-09-27 04:00 · somebody
kind set kind set to peptide: palette r1 · 2026-09-27 04:00 · somebody
fact added identity: PubChem CID 9831659: Ipamorelin, C38H49N9O5, 711.9 g/mol. · 2026-09-27 04:00 · somebody
fact added identity: CAS registry number 170851-70-4. · 2026-09-27 04:00 · somebody
fact added identity: IUPAC name: (2S)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2S)-2-[(2-amino-2-methylpropanoyl)amino]-3-(1H-imidazol-5-yl)propanoyl]a · 2026-09-27 04:00 · somebody
fact added summary: Ipamorelin is the pentapeptide Aib-His-D-2-Nal-D-Phe-Lys-NH2, described as the first selective growth hormone secretagog · 2026-09-27 04:00 · somebody
fact added history: In a phase 2 randomized trial of 114 bowel-resection patients with postoperative ileus, it was well tolerated but did no · 2026-09-27 04:00 · somebody
citation added pmid 9849822 cited as preclinical: Development and pharmacology of ipamorelin · 2026-09-27 04:00 · somebody
citation added pmid 25331030 cited as emerging: Phase 2 randomized trial in postoperative ileus: no significant difference from placebo · 2026-09-27 04:00 · somebody

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.